NCT04380324 - A Study of NKTR-358 (LY3471851) in Healthy Participants | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 19, 2017

Primary Completion Date

January 20, 2019

Study Completion Date

January 20, 2019

Conditions

Healthy

Interventions

DRUG

LY3471851

LY3471851 drug product is a sterile liquid for SC injection that may be diluted with sterile 0.9% sodium chloride solution for injection (USP) prior to administration.

DRUG

Placebo

The placebo dosing solution is 0.9% sodium chloride for injection (USP).

Trial Locations (1)

66219

PRA Health Sciences, Lenexa